Navigation Links
FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
Date:10/21/2011

TITUSVILLE, N.J., Oct. 21, 2011 /PRNewswire/ -- Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study.  ARTEMIS evaluated the efficacy and safety of PREZISTA with ritonavir (r) vs. lopinavir/r in combination with other antiretrovirals (ARVs) for the treatment of human immunodeficiency virus (HIV-1) in treatment-naive patients.

"Since its launch in 2006, PREZISTA has become one of the most prescribed antiretroviral agents in the protease inhibitor class.  Having data showing the efficacy, safety, and tolerability of PREZISTA over 192 weeks should give added confidence to healthcare providers who are considering PREZISTA as an option for their patients who are starting treatment for the first time," said Vanessa Broadhurst, President, Janssen Therapeutics.

PREZISTA was developed by Tibotec Pharmaceuticals and is marketed in the U.S. by Janssen Therapeutics. PREZISTA, co-administered with ritonavir (PREZISTA/ritonavir), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection.

This indication is based on analyses of plasma HIV-1 RNA levels and CD4+ cell counts from two controlled Phase 3 trials of 48 weeks duration in antiretroviral treatment-naive and treatment experienced patients and two controlled Phase 2 trials of 96 weeks duration in clinically advanced, treatment-experienced adult patients.

In treatment-experienced adult patients, the following points should be considered when initiating therapy with PREZISTA/r:

  • Treatment history and, when available, genotypic or phenotypic testing should guide the use of PREZISTA/r.
  • The use of other active agents with PREZISTA/r is associated with a greater likelihood of treatment response.

  • ARTEMIS 192-Week Study
    '/>"/>

    SOURCE Janssen Therapeutics, Division of Janssen Products, LP
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
    2. FDA Approves Combination Therapy Juvisync
    3. FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
    4. FDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
    5. FDA Approves Soliris for Rare Pediatric Blood Disorder
    6. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
    7. FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer
    8. FDA Approves Firazyr To Treat Acute Attacks of Hereditary Angioedema
    9. FDA Approves Adcetris to Treat Two Types of Lymphoma
    10. FDA Approves the First Specific Treatment for Scorpion Stings
    11. Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... , Feb. 26, 2015  MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the Cowen and Company 35 th ... 10:40 a.m. Eastern time from the Boston Marriott Copley Place. ... www.meipharma.com . A replay will be available approximately one ...
    (Date:2/26/2015)... 26, 2015 Ultrasound World will celebrate ... Beach Hilton to provide the latest advances, trends, ... professionals from around the world. UE ... leaders in the field of air- and structure-borne ... continues with this year,s conference. As with previous ...
    (Date:2/26/2015)... Fla. , Feb. 26, 2015   Coverall ... cleaning franchised businesses, today celebrates 30 Years of Clean, ... anniversary. Coverall started in 1985 as ... Calif. and is now a leading global ... years, Coverall,s passion and mission have remained consistent: To ...
    Breaking Medicine Technology:MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2Coverall Celebrates 30 Years of Clean 2Coverall Celebrates 30 Years of Clean 3
    ... Untold Numbers of Consumers Still Left Disabled By Its ... GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super ... its denture adhesive products.  The pharmaceutical giant has added the potentially ... consuming large quantities of zinc over an extended period of time ...
    ... , , SHANGHAI , ... WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... announced that it will release financial results for the fourth quarter of ... 8, 2010 (which will be Tuesday morning, March 9, 2010 ...
    Cached Medicine Technology:Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams 2Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams 3WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release 2WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release 3
    (Date:2/27/2015)... 2015 First Choice Emergency Room ... today. The new facility is located 25551 E. Smoky Hill ... are pleased to be a part of the Aurora community ... care here,” said Dr. Dombro, Facility Medical Director of First ... To celebrate the opening, First Choice Emergency Room made a ...
    (Date:2/27/2015)... Lewis Clinic Dentistry has extended its business hours to ... services available for patients who cannot make regular weekday appointments. ... Dentistry said, “Yes, we have extended our business hours so ... their busy schedules and work can come on the weekends. ... lives beautiful and smiling.” He further added, “We are working ...
    (Date:2/27/2015)... Dr. James Rybacki, author of The Essential Guide ... 6 people die every day in the US from alcohol ... the problem and help people understand crucial interactions. The Essential ... the following questions:, Is your college ... what binge drinking is? , Are you aware ...
    (Date:2/27/2015)... (PRWEB) February 27, 2015 Javon ... The program, which is free and open to the ... 8:15-9:30 am, at the Janesville Mall Food Court, 2500 ... health screenings, door prize drawings, and an educational health-related ... up for membership in Stride for Health. , March ...
    (Date:2/27/2015)... 2015 Developers of FCPX plugins and ... transition plugin for Final Cut Pro X ... users total control over comic book style transitions ... CEO of Pixel Film Studios. “TransComic was professionally designed ... interface.” , Transitions from one comic frame to the ...
    Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Aurora, Colorado 2Health News:Lewis Clinic Dentistry Extends Business Hours 2Health News:6 People Die Each Day From Alcohol Poisoning, new Essential Guide to Prescription Drugs eBook seeks to prevent interactions and deaths 2Health News:Pixel Film Studios Released a New Transition Plugin Entitled TransComic Exclusively for Final Cut Pro X Users 2
    ... of dangerous tau protein , , TUESDAY, Aug. 21 (HealthDay ... implicated in Alzheimer,s disease has proven effective in mice, ... damaging tangles in the memory center of the brains ... York University Medical Center (NYUMC). , However, the new ...
    ... finds , TUESDAY, Aug. 21 (HealthDay News) -- Claims of ... documentation or validation, experts report in the Aug. 22/29 issue ... , A team of researchers in Greece analyzed 77 studies ... (66.2 percent) of these claims were decided in advance of ...
    ... study found , , TUESDAY, Aug. 21 (HealthDay News) -- ... had high blood pressure in a new study, showing ... , "Hypertension in children is very underdiagnosed," said study ... at the Center for Information Technology Leadership at Harvard ...
    ... baked food compound poses no threat, major study finds , , ... little or no link between breast cancer and acrylamide, a ... the largest epidemiological study on the subject conducted to date. ... in the diet does not appear to be an important ...
    ... effective in preventing the behavioral and academic problems associated ... five-year study led by researchers at Lehigh Universitys College ... funded by the National Institute of Mental Health (NIMH), ... aged 3 to 5 who have shown significant symptoms ...
    ... shown that an 800-year-old formula, Four-Agents Decoction (Si Wu ... cycles of treatment; however, a beneficial effect may be ... treatment length used in this study are not associated ... August 15 issue of the online, open-access journal PLoS ...
    Cached Medicine News:Health News:Gene Studies of Male-Female Differences Often Flawed 2Health News:Doctors Often Miss High Blood Pressure in Kids 2Health News:Doctors Often Miss High Blood Pressure in Kids 3Health News:Acrylamide Won't Raise Breast Cancer Risk 2Health News:Acrylamide Won't Raise Breast Cancer Risk 3Health News:Acrylamide Won't Raise Breast Cancer Risk 4Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 2Health News:Non-medicinal treatment touted for pre-schoolers with ADHD 3Health News:Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea? 2
    ... Superior optics and workmanship are the ... with temperature sensitivity in mind. The top ... unequalled illumination, eliminating shadows while remaining cool ... models are available with 10x to 44x ...
    ... expandability: the first inverted microscope to take ... space. Multi-port design enables optical input/output of ... of illumination and detector equipment. Extendable "Stratum ... optional light source and other attachments within ...
    ... imaging camera system designed for scientific ... megapixel digital cameras provides high-resolution, full-color ... on a PC via its Firewire ... previewing capability is accompanied by automatic ...
    ... Color video camera with direct digital ... and fluorescence applications. Olympus wide array of ... the image quality and flexibility you need ... cameras provide a high-resolution, real-time image of ...
    Medicine Products: